Skip to main content

Table 12 Incidences of any DVT (up to POD10) and major bleeding (up to POD28) in propensity-matched fondaparinux- or enoxaparin-treated groups (THA)

From: Venous thromboembolism after total joint arthroplasty: results from a Japanese multicenter cohort study

Events

Fondaparinux

Enoxaparin

Risk ratio (95% CI)

P value

n = 144

n = 144

DVT

8/144 (5.6%)

16/144 (11.1%)

0.73 (0.53-0.99)

0.134

Major bleeding

7/144 (4.9%)

0/144 (0%)

-

0.022

  1. CI, confidence interval; DVT, deep vein thrombosis; POD, postoperative day; THA, total hip arthroplasty.
Back to article page

Arthritis Research & Therapy

ISSN: 1478-6362

Contact us